Covidien opens China Technology Center, R&D unit in Shanghai

By Admin
Leading global provider of healthcare products Covidien announced the opening of its China Technology Center and Research and Development facility in S...

Leading global provider of healthcare products Covidien announced the opening of its China Technology Center and Research and Development facility in Shanghai.

"The establishment of this R&D facility in Shanghai strengthens Covidien’s continued commitment to provide innovative new products. It will also help healthcare providers worldwide improve patient care and extend healthcare delivery to more people and more places," said José E. Almeida, Chairman, President and CEO of Covidien.  

China is a key market in our global strategy, and this investment is a reflection of our strategic initiative. With a total investment of $45 million over a three year period, the China Technology Center will employ more than 300 people.

The facility spans more than 100,000 square feet, houses 17 laboratories and has state-of-the-art surgical and simulation suites that enables healthcare professionals to be actively involved in medical device design and development process. 

Shanghai unit will provide a focal point to develop local Chinese talent and groom the next generation of medical innovators for the industry.  

Dong Wu, Vice President, China RA&D Covidien said, “By collaborating closely with local medical experts who use our products, we can tailor devices to meet the demands of other emerging markets and China.”  Mr. Covidien also said, “We recognize the immense potential of basing an R&D facility in Shanghai. This location will help us tap into internationally renowned experts based here in China, including the world-class engineering talent. We believe this collaboration will drive innovation in China and across the emerging markets healthcare landscape.”

Covidien is a global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through the clinical leadership and excellence. The company has 43,000 employees worldwide in over 65 countries and its products are sold in more than 140 countries.

Share
Share

Featured Articles

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey

McKinsey report reveals cost inflation is forcing AMCs to find operational efficiencies, or face cutting back on crucial training & education programmes

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance

McKinsey: ‘Women’s Healthcare Neglected for Decades'

Digital Healthcare